ArticleCancer immunology research2019

Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer.

Kristin G Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.